<DOC>
	<DOC>NCT02527005</DOC>
	<brief_summary>Randomized controlled single blind prospective comparative study</brief_summary>
	<brief_title>A Comparative Study of Azithromycin and S-P as Prophylaxis in Pregnant HIV+ Patients</brief_title>
	<detailed_description>This study is intended to be a randomized controlled single blind prospective comparative study conducted to compare the efficacy of three monthly doses of sulphadoxine-pyrimethamine as intermittent preventive therapy for malaria with azithromycin in HIV positive pregnant women</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Fanasil, pyrimethamine drug combination</mesh_term>
	<mesh_term>Sulfadoxine</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<criteria>Pregnant HIV positive patients, Gestational age 16 weeks and above, No history of azithromycin or sulphadoxinepyrimethamine use four weeks prior to recruitment Anaemia packed cell volume less than 30%, preexisting medical conditions diabetes mellitus, hypertension, allergy to sulphadoxinepyrimethamine or azithromycin</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>IPT</keyword>
	<keyword>malaria</keyword>
	<keyword>pregnant</keyword>
	<keyword>HIV positive</keyword>
</DOC>